Digitoxin added to guideline-directed medical therapy improved outcomes among patients with heart failure and reduced ejection fraction (HFrEF), the DIGIT-HF trial showed. The cardiac glycoside ...

In a new post hoc analysis of the AFFIRM trial, the use of digoxin was not associated with an increased risk of death or hospitalizations in patients with paroxysmal and persistent AF. This ...

Treatment with digitoxin cut the absolute risk of all-cause mortality and hospitalization for worsening HF by 4.6% compared with placebo over a median follow-up of 36 months (HR 0.82; 95% CI 0.69-0.98 ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

What is digoxin, and how does it work? What are the lanoxin tabs 25 mg for digoxin? What are the side effects of digoxin? Many digoxin side effects are dose dependent and happen when blood levels are ...

Marlex Pharmaceuticals said Digoxin tablet bottles got labeled with incorrect strengths. Heart failure and drug toxicity might result.

Study results show mortality benefit from low-dose digitoxin for heart failure in symptomatic patients with reduced ejection fraction.

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early trial suggests. But questions remain.

Marlex Pharmaceuticals is recalling 1 lot of Digoxin Tablets 0.125mg and 1 lot of Digoxin Tablets 0.25mg due to a label mix-up.

Digitoxin reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and a reduced ejection fraction (HFrEF), according to ...

New Castle, Delaware, Marlex Pharmaceuticals, Inc. is voluntarily recalling one lot of Digoxin Tablets USP, 0.125mg and one lot of Digoxin Tablets USP, 0.25mg to the consumer level due to Label ...